Cap dependent endonuclease inhibitor

The invention provides a compound as shown in formula (I) for inhibiting influenza virus replication, and pharmaceutically acceptable salt, metabolite or prodrug thereof, wherein the formula is described in the specification. The compound can be used for preparing a medicine for treating influenza....

Full description

Saved in:
Bibliographic Details
Main Authors LIN ZHUQIANG, CHEN HONGQUAN
Format Patent
LanguageChinese
English
Published 09.11.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention provides a compound as shown in formula (I) for inhibiting influenza virus replication, and pharmaceutically acceptable salt, metabolite or prodrug thereof, wherein the formula is described in the specification. The compound can be used for preparing a medicine for treating influenza. The invention also discloses a method for preparing the substances and a composition comprising the compound and a pharmaceutically acceptable carrier. 本发明提供一种用于抑制流感病毒复制的式(I)化合物、其药学上可接受的盐、代谢物或前药：所述化合物能够用于制备成治疗流感的药物。本发明还公开了制备它们的方法以及包含所述化合物与药学上可接受的载体的组合物。
Bibliography:Application Number: CN202010372597